RecruitingPhase 3NCT06617325
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Sponsor: UCB Biopharma SRL
Kansas City, KS · +62 more sites
4 recruiting lupus studies with a site in Kansas City, KS.
Sponsor: UCB Biopharma SRL
Kansas City, KS · +62 more sites
Sponsor: Cabaletta Bio
Kansas City, KS · +20 more sites
Sponsor: National Cancer Institute (NCI)
Fairway, KS · Hays, KS · Kansas City, KS · +48 more sites
Sponsor: Allogene Therapeutics
Kansas City, KS · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.